Pulsatilla Compositum description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Pulsatilla Compositum

Heel Inc

Pulsatilla Compositum 2.2 ml Injection


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

PULSATILLA COMPOSITUM DESCRIPTION


PULSATILLA COMPOSITUM INDICATIONS AND USAGE











PULSATILLA COMPOSITUM DOSAGE AND ADMINISTRATION



Adults and children 7 years and older:Children ages 2 to 6




WARNINGS AND PRECAUTIONS

Warnings and Precautions




To report SUSPECTED ADVERSE REACTIONS, contact Heel Inc. at 1.800.920.9203 or info@heelusa.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatchPulsatilla Compositum

Pulsatilla Compositum

PULSATILLA VULGARIS and SULFUR and CORTISONE ACETATE INJECTION

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:50114-7060
Route of Administration INTRADERMAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
PULSATILLA VULGARIS PULSATILLA VULGARIS 6 [hp_X]
SULFUR SULFUR 8 [hp_X]
CORTISONE ACETATE CORTISONE 18 [hp_X]

Inactive Ingredients

Ingredient Name Strength
SODIUM CHLORIDE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 2.2 in 1 AMPULE
2 NDC:50114-7060-1 10 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
2009-04-30


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.